Maryland-based Rock Spring Ventures hopes to raise $100 million by the end of this year to invest in mid-Atlantic biotech and healthcare start-ups, according to the Washington Business Journal. Managing partners tell the paper that they've already begun to evaluate potential investment candidates even as they continue to raise funding. Report